INTRODUCTION
============

The centrosome is the primary site of microtubule nucleation in animal somatic cells. Centrosomes control a number of processes, including mitotic spindle formation, cell polarity, motility, and intracellular trafficking. Defects in centrosome number or function compromise stem cell division, DNA-damage responses, and faithful chromosome segregation, leading to a variety of diseases, such as microcephaly, dwarfism, ciliopathies, and cancer. Centrosome numbers are therefore under strict control, with centrosome duplication limited to once per cell cycle.

The centrosome consists of a pair of centrioles---cylindrical structures of 0.2--0.5 μm composed of nine microtubule triplets. Centrioles are surrounded by electron-dense, pericentriolar material (PCM), which serves as the main microtubule nucleation site within the centrosome, and nearby lie the centriolar satellites, electron-dense granules that contribute to centrosome function, possibly by mediating protein transport to the centrosome ([@B12]). Centriole duplication is initiated in late G1/early S phase. Each centriole, the so-called mother centriole, templates the assembly of a procentriole. The wall of procentrioles is initially composed of nine singlet microtubules, but these are converted to doublets and/or triplets as the procentrioles elongate to form a new centriole, the daughter centriole ([@B23]; [@B19]; [@B5]; [@B35]). Procentriole assembly depends on a structural scaffold. In *Caenorhabditis elegans*, procentrioles form around a central tube comprising the conserved proteins Sas-5 and Sas-6 ([@B13]; [@B15]; [@B29]). In other organisms, such as *Chlamydomonas*, *Drosophila*, and vertebrates, the procentriole forms around a cartwheel-like structure ([@B11]). The cartwheel consists of a central hub surrounded by nine radial spokes. This ninefold-symmetrical structure is believed to dictate the structure of the nascent centriole. Sas-6 is a highly conserved protein that localizes to the proximal end of the mother centriole at the position of the cartwheel ([@B28]; [@B45]). Recent reports show that Sas-6 oligomerizes into a ring-like structure with nine coiled-coil domains projecting outward, thus closely resembling the central hub and the nine radial spokes that constitute the cartwheel ([@B27]; [@B49]).

Bld10/Cep135 is another highly conserved centrosomal protein involved in cartwheel assembly ([@B10]). Analysis of *Chlamydomonas* mutants with defective flagella demonstrated a requirement for Bld10 in the assembly of basal bodies, which are analogous to centrioles ([@B32]). Expression of *bld10*-deletion mutants in *Chlamydomonas* caused the formation of centrioles with altered numbers of centriolar microtubules due to reduced cartwheel diameters ([@B24]). Bld10 is also required for basal body formation in *Paramecium* and, in both protists, it localizes to the tips of the cartwheel spokes ([@B32]; [@B24]; [@B25]). Its absence destabilized Sas-6p at the cartwheel hub, even though Bld10 was not required for the establishment of a structure with ninefold symmetry ([@B34]; [@B25]). In *Tetrahymena*, Bld10 shows a similar localization to the outer cartwheel and is also required for basal body assembly and maintenance ([@B4]). In *Drosophila*, Bld10 depletion led to defects in centriole duplication and PCM maturation ([@B16]), and *bld10* mutants exhibited centrioles and basal bodies that were shorter than controls ([@B33]). Recent data indicate that cartwheels can assemble in the absence of *Drosophila* Bld10, although they appear to lack stability ([@B38]).

The mammalian orthologue of Bld10, Cep135, localizes to the proximal lumen and exterior of centrioles, as determined by immuno--electron microscopy analyses in hamster ([@B36]) and human ([@B28]) cells. Recent work using superresolution three-dimensional structured illumination microscopy in human cells localized the principal Cep135 signal to the proximal end of mother centrioles, with a weaker signal on nascent daughter centrioles ([@B41]). Depletion of Cep135 prevented PLK4-induced centriole overduplication in human cells ([@B28]). Cep135 deficiency caused the delocalization of other centrosomal proteins from the proximal end of the centrioles ([@B48]; [@B26]), and recent data demonstrated significant centriole abnormalities resulting from Cep135 depletion in human cells ([@B30]). Furthermore, a mutation in *Cep135* has been reported to cause primary microcephaly ([@B24a]), highlighting the potential importance of Cep135 in centrosome function. Despite these observations, the precise function of Cep135 in the vertebrate centrosome is not well understood.

In this study, we use gene targeting in the genetically tractable DT40 cell line to disrupt Cep135 function. *Cep135*-knockout cells are viable and capable of centriole duplication. A small increase in monopolar spindles is observed, with a concomitant reduction in centriole numbers, indicative of minor perturbations of centriole biogenesis. Although the centrosomes appear generally intact, we note an atypical electron-dense structure within centrioles. Furthermore, centriole amplification is significantly elevated during prolonged S-phase in cells that lack Cep135. These data indicate a role for Cep135 in centriole integrity and the control of centrosome number during S-phase delay.

RESULTS AND DISCUSSION
======================

To investigate the effect of Cep135 deficiency on centrosome function and structure, we used targeted gene disruption in the hyperrecombinogenic chicken B-cell line, DT40. We identified the chicken *Cep135* orthologue from the National Center for Biotechnology Information database and confirmed its sequence by 5′ rapid amplification of cDNA ends and reverse transcription (RT)-PCR analysis of DT40 RNA. The large size of the *Cep135* locus precluded simple disruption of the entire gene. Therefore, as shown in [Figure 1A](#F1){ref-type="fig"}, two knockout strategies were chosen to disrupt the *Cep135* locus: the first, using construct A, deleted the genomic region encoding exons 1--4, and the second, using construct B, deleted the region encoding exons 5--9 ([Figure 1A](#F1){ref-type="fig"}). Sequential gene targeting with either of these constructs yielded several clones in which the *Cep135* locus was disrupted ([Figure 1, B and C](#F1){ref-type="fig"}). To indicate which strategy was used, clones generated with construct A are described as *Cep135* knockout (KO) A1 and A2 and those with construct B as *Cep135* KO B1 and B2.

![Gene targeting of chicken *Cep135.* (A) Schematic shows the *chicken Cep135* genomic locus and the targeting constructs used to replace either exons 1--4 (construct A) or exons 5--9 (construct B) of *Cep135* with the indicated drug resistance cassettes. The positions of the allele-specific and the resistance cassette--specific primers used for PCR-based genotypic analysis are shown as capital letters (A--G). (B, C) Agarose gel images showing the allele-specific PCR products from the wild-type (*Cep135^+/+^*), (B) *Cep135^−/−^* (KO) A1 and A2, and (C) *Cep135^−/−^* (KO) B1 and B2 cell lines. Capital letters correspond to primer pairs indicated in A. Bsr, blasticidin; Neo, neomycin; Puro, puromycin. (D) An agarose gel image showing the *Cep135* and β-actin--specific RT-PCR products from the wild-type and *Cep135* KO A1 and A2 DT40 cell lines. (E) qPCR analysis of several *Cep135* exons in clones of the indicated genotype. Histogram indicates *C*~T~ values referenced to *glyceraldehyde-3-phosphate dehydrogenase* (*GAPDH*) and normalized to wild-type values. Error bars indicate SEM from two triplicate experiments.](2645fig1){#F1}

RT-PCR analysis showed that the full-length *Cep135* transcript was absent from *Cep135* KO A1 and A2 ([Figure 1D](#F1){ref-type="fig"}), although a weak signal from the region 3′ of the deleted sequence was observed (data not shown), suggesting that some downstream transcript remains in cells. Similarly, quantitative RT-PCR on clones B1 and B2 showed that no transcript was detectable from the deleted exon 6, although sequences from the neighboring exons 4 and 13 were present at levels similar to those seen wild-type cells ([Figure 1E](#F1){ref-type="fig"}). To investigate whether *Cep135*-targeted cells were indeed deficient in Cep135 protein expression, we placed a tandem affinity purification (TAP) tag ([@B8]), comprising protein G and streptavidin-binding protein, in frame with the last exon of *Cep135* by gene targeting in wild-type, A1, and B1 cells ([Figure 2, A and B](#F2){ref-type="fig"}). These cell lines were called TAP KO A1 or TAP KO B1. Western blots with anti--protein G antibodies revealed a 150-kDa band in TAP-wild-type cells. This corresponds to full-length Cep135 plus the TAP tag, which has a molecular weight of 17 kDa. In TAP KO A1 and TAP KO B1 cells, however, no product was detected, suggesting that the *Cep135* KO cell lines are protein null ([Figure 2C](#F2){ref-type="fig"}). To further confirm that the cell lines were protein null, we examined Cep135 protein levels by immunoblot with an antibody raised against the C-terminal end of the human Cep135 coding sequence ([@B36]). As shown in [Figure 2D](#F2){ref-type="fig"}, this antibody detected no bands corresponding to Cep135 in *Cep135* KO cells. Consistently, despite robust centrosomal signals in wild-type cells, immunofluorescence microscopy failed to detect a centrosomal signal in TAP KO A1 (data not shown) or TAP KO B1 cells when using antibodies directed against the TAP tag ([Figure 2E](#F2){ref-type="fig"}). Similarly, antibodies to human Cep135 did not reveal a centrosomal signal in KO A1 cells ([Figure 2F](#F2){ref-type="fig"}). Together these data clearly demonstrate that our targeting of *Cep135* resulted in the loss of the full-length Cep135 protein in both KO A1 and KO B1 cell lines. We therefore used the two cell lines interchangeably to assay the loss-of-function phenotype of *Cep135.*

![*Cep135^−/−^* cells lack Cep135 protein. (A) TAP-Cep135 knock-in construct designed to introduce a C-terminal TAP tag to Cep135. Targeting of this construct into the *Cep135* locus removes the endogenous stop codon and allows expression of the TAP sequence as a fusion with Cep135. (B) PCR using the primers HI shown in A to assess correct integration of the TAP tag in the indicated clones. (C) Western blots of heterozygous Cep135-TAP--tagged clones of the indicated genotype using antibodies to protein G, a component of the TAP tag. We used β-actin as a loading control. (D) Western blots of human osteosarcoma U2OS and DT40 wild-type and *Cep135* KO A1 and A2 total protein extracts with anti-Cep135 antibody. Scc1 serves as a loading control. (E) Localization of TAP-Cep135 protein products in the indicated clones visualized with structured illumination microscopy. Centrin3 (red) was used as a distal centriolar marker, and DNA was stained with Hoechst 33258 (blue). TAP-Cep135 was detected by antibodies against protein G (green). Scale bar, 3 μm. (F) Immunofluorescence microscopy analysis of clones of the indicated genotype. Cells were stained with antibodies against Cep135 (green) and γ-tubulin (red) as a reference marker. Scale bar, 10 μm.](2645fig2){#F2}

We next analyzed the proliferative properties of *Cep135* KO cells. As shown in [Figure 3A](#F3){ref-type="fig"}, Cep135-deficient cells proliferated at a rate indistinguishable from that of wild-type cells. Flow cytometry analysis of the *Cep135*-targeted cells showed no difference from wild type with respect to the proportions of the population undergoing DNA replication ([Figure 3B](#F3){ref-type="fig"}) or mitosis ([Figure 3C](#F3){ref-type="fig"}). To extend our analysis of mitosis in Cep135-deficient cells, we measured the duration of mitosis by live cell imaging using wild-type and Cep135-deficient cells that stably expressed histone H2B-RFP ([@B18]). The mean time taken from chromosome condensation to decondensation was found to be 42.9 min in both wild-type cells and Cep135-deficient cells ([Figure 3D](#F3){ref-type="fig"}), indicating that mitotic progression is normal in cells that lack Cep135. Although the data presented in this figure were obtained from clones generated with construct A, those that resulted from targeting with construct B showed similar proliferative characteristics with no significant difference from wild-type cells (data not shown). These results indicate that full-length Cep135 is dispensable for cell viability and normal cell cycle progression in DT40 cells. Given the degree to which Cep135 is evolutionarily conserved, we had expected a stronger phenotype, so an obvious issue is that of potential redundancy. Extensive BLAST searching of the chicken genome and EST databases has not provided any evidence for a duplication of *Cep135*. In a detailed bioinformatic analysis of Cep135, [@B10]) found that testis-specific protein 10 (Tsga10) shared high levels of sequence similarity with Cep135 within a specific, conserved region. We confirmed that *Tsga10* was expressed in DT40 cells (Supplemental Figure S1C). To test whether Tsga10 might serve redundant functions with Cep135, we disrupted *Tsga10* in *Cep135*-knockout cells, using the strategy shown in Supplemental Figure S1, A and B, and confirmed the loss of *Tsga10* expression (Supplemental Figure S1C). We found no significant alteration of spindle integrity in *Cep135*/*Tsga10* knockouts (Supplemental Figure S1D) and no effect on centriole number in monastrol-induced monopoles (Supplemental Figure S1E). From these data, we conclude that *Cep135* is nonredundant in DT40 cells.

![*Cep135* null cells are viable and show no proliferative defect. (A) Proliferation analysis of *Cep135* KO DT40 cells. Cells were seeded at 10^5^/ml, and cell numbers were counted over 72 h. Data show mean ± SD of three separate experiments. (B) Quantitative cell cycle analysis of asynchronous cells of the indicated genotype stained for incorporated BrdU and total DNA levels. The G1 (bottom left), S (top), and G2/M (bottom right) gates are indicated in boxes, and the numbers refer to the percentage of cells detected in each of the gates averaged from three separate experiments. (C) Mitotic indices for wild type and two *Cep135* KO clones were determined by M-phase marker phosphorylated histone H3 (PH3). The numbers refer to the percentage of cells in M phase averaged from three separate experiments. (D) Duration of mitosis in wild-type and *Cep135* KO cells. Graph shows the mean of time in mitosis and the mean of time from the beginning of prometaphase to the end metaphase and the mean of time from the beginning of anaphase to the end of telophase. Each data point represents one cell. Data show mean ± SD for the 50 individual cells analyzed in three different experiments.](2645fig3){#F3}

Our time-lapse data suggested that mitotic spindle assembly was not greatly perturbed in Cep135-deficient cells. Indeed, fixed-cell analysis indicated that mitotic spindles in the majority of Cep135-deficient cells were bipolar, with γ-tubulin localized exclusively at the spindle poles and the chromosomes aligned at the metaphase plate, as in wild-type cells ([Figure 4A](#F4){ref-type="fig"}). We observed, however, a small increase in the number of Cep135-deficient cells with monopolar spindles compared with wild-type cells ([Figure 4B](#F4){ref-type="fig"}). Bipolar spindle lengths were 7.66 ± 0.8 μm in Cep135-deficient cells and 7.41 ± 1.0 μm in wild-type controls, showing no significant difference (Supplemental Figure S2). To allow accurate scoring of centriole numbers, we arrested wild-type and Cep135-deficient cells in mitosis by monastrol, a small-molecule inhibitor of Eg5, the kinesin responsible for centrosome separation. Monastrol treatment therefore causes formation of monopoles that contain both centrosomes, each with two centrioles ([Figure 4C](#F4){ref-type="fig"}). Most monopoles in wild-type cells contained the normal centriole complement of four, with only 4% of the poles displaying one or two centrioles. Some of these may correspond to centriole pairs that could not be resolved by confocal microscopy. In contrast, 26% of monopoles in Cep135-deficient cells contained only one or two centrioles ([Figure 4D](#F4){ref-type="fig"}). Collectively these data demonstrate that although Cep135 is not essential for centriole biogenesis, its loss dysregulates control of centrosome number in a small proportion of cycling cells. Despite the increase in monopolar spindles and reduction in centriole numbers in Cep135-deficient cells, we observed only minor changes in proliferation rate and mitotic index. It is conceivable that our assays are not sensitive enough to detect subtle changes. Indeed, DT40 cells lacking another centrosomal protein, CEP63, exhibit \>30% monopolarity and a dramatic reduction in centriole numbers, yet we observe only a 15% increase in doubling time ([@B40]).

![Analysis of mitosis and MT nucleation in Cep135-deficient cells. (A) Microscopy analysis of mitotic phases in wild-type and *Cep135* KO cells. Immunofluorescence images of mitotic cells of the indicated genotype stained with antibodies against α-tubulin (red) and γ-tubulin (green); DNA is labeled with Hoechst 33258 (blue). Bar, 10 μm. (B) Bipolar, multipolar, and monopolar spindles in wild-type and *Cep135* KO B1 and B2 cells were quantified in four independent experiments. Histogram shows mean + SEM of data from 150 mitotic cells per experiment. \**p* ≤ 0.05 in comparison with wild-type cells. (C) DT40 WT and *Cep135* KO B1 were treated with 125 μM monastrol for 16 h. Cells were stained for antibodies against TACC3 (red) and centrin3 (green), and DNA is labeled with Hoechst 33258 (blue). Scale bar, 5 μm. (D) The number of centrioles within monopoles derived from monastrol-treated wild-type and KO B2 cells was counted in two independent experiments. Histogram shows mean + SEM of data from 50 mitotic cells per experiment. \**p* ≤ 0.05 in comparison with wild-type cells. (E) Immuno­fluorescence microscopy analysis of microtubule nucleation in wild-type DT40 cells before and after release from 3-h arrest in 1 μg/ml nocodazole at 4°C. Cells were stained with antibodies to α-tubulin (green) and centrin2 (red). DNA (blue) was visualized with 4′,6-diamidino-2-phenylindole (DAPI) staining before imaging. Scale bar, 10 μm. (F) Quantitation of percentage of cells of the indicated genotype with aster nucleation after microtubule regrowth for 1 min at 39.5°C. Histogram shows mean ± SD of three separate experiments in which at least 200 cells per experiment were counted. (G) Transmission electron micrographs of wild-type and *Cep135^−/−^* cells showing centriolar appendages and microtubules associated with the centrosome. Scale bar, 100 nm.](2645fig4){#F4}

We next examined the ability of Cep135-deficient centrosomes to nucleate microtubules after depolymerization of microtubules (MTs) after cold and nocodazole treatment. We found that in the absence of Cep135, cells were capable of nucleating MTs as well as wild-type cells, implying that Cep135 is not essential for efficient microtubule nucleation in DT40 cells ([Figure 4, E and F](#F4){ref-type="fig"}). Additional evidence for normal microtubule nucleation in *Cep13*5 KO cells came from transmission electron microscopy (TEM) analysis. As shown in [Figure 4G](#F4){ref-type="fig"}, Cep135-deficient centrosomes associate with microtubules. Together with the data showing normal mitoses in *Cep135* KO cells, these results support the conclusion that there is no major effect of *Cep135* disruption on the microtubule-organizing activity of the centrosome in DT40 cells.

To investigate the effects of Cep135 deficiency on centrosome composition, we next used immunofluorescence microscopy with antibodies specific to proteins localizing to different components of the centrosome. Analysis of components of the centrioles (centrin2, Cep76, ninein, glutamylated tubulin), cartwheel (Sas-6), PCM (γ-tubulin, Aurora A), and pericentriolar satellites (PCM1) revealed no difference between wild-type and *Cep135* KO cells ([Figure 5, A and B](#F5){ref-type="fig"}), indicating that Cep135 deficiency did not have any detectable effect on centrosome composition or maturation. We also examined the centrosome ultrastructure in the absence of Cep135 by TEM. As shown in [Figure 6A](#F6){ref-type="fig"}, Cep135-deficient cells, like wild-type controls, contained orthogonally arranged centrioles of nine triplet microtubules, surrounded by electron-dense PCM, with the procentrioles elongating orthogonally from the mother centriole. Inner centriole diameters were 183 ± 23 nm in single sections of wild-type cells and 173 ± 18 nm in *Cep135*-null cells. Longitudinal sections of wild-type centrioles showed the mean centriole length to be 370 ± 28 nm (*N* = 20), whereas the *Cep135-*null centrioles averaged 350 ± 30 nm (*N* = 29). Together these data showed no major effect of Cep135 deficiency on centriole size. Of interest, we observed an unusual, electron-dense structure in longitudinal sections of *Cep135*-knockout centrioles that was not present in sections of wild-type centrioles ([Figure 6B](#F6){ref-type="fig"}). We detected this structure in 34 of 40 *Cep135*-deficient centrosomes analyzed but not in any of 47 wild-type centrosomes. This structure was observed roughly halfway along the length of the centriole (mean 0.42 ± 0.09 centriole length from the proximal end; *N* = 20). Because such structures were observed in 34 of 40 *Cep135*-deficient centrioles, they are unlikely to be restricted to mother or daughter centrioles. Observation of the structure in three independently generated *Cep135*-null cell lines confirms that it arose due to the loss of Cep135. Based on the known effects of Cep135 or Bld10 deficiency in other model systems ([@B32]; [@B24]; [@B28]), our prediction had been that Cep135 loss would strongly impair centriole organization. The absence of such effect beyond the appearance of the electron-dense structure was surprising.

![Centrosome composition is normal in Cep135-deficient cells. (A) Immuno­fluorescence microscopy analysis of wild-type and *Cep135* KO cells stained with the following antibodies to centrosomal or centrosome-associated proteins: γ-tubulin (red), centrin2, Cep76, Sas-6, PCM1, ninein, glutamylated tubulin, and Aurora A (green). Cells were then counterstained with DAPI (blue). Scale bar, 5 μm. (B) Immunoblot of Sas-6 levels in cells of the indicated genotype. α-Tubulin was used as a loading control, and cell extract from human HCT116 cells served as a positive control for the Sas-6 antibody.](2645fig5){#F5}

![An atypical centriolar structure in longitudinal sections of Cep135-deficient centrioles (A) Transmission electron micrographs of wild-type and Cep135-deficient (KO A1) cells showing i) centriole duplication, ii) composition of nine triplet microtubules, iii) PCM integrity on centrosomes. (B) Transmission electron micrographs of wild-type and *Cep135* KO centrioles. Note that the unusual electron-dense structure (indicated by the red arrow) is only observed in *Cep135* KO cells. Short scale bar, 100 nm; long scale bar, 500 nm.](2645fig6){#F6}

Cep135 is implicated in the Plk4-controlled cascade that regulates centriole duplication. Downstream of Plk4, Sas-6, CENPJ (CPAP), and CP110 are recruited to the nascent procentrioles at different stages during centriole formation ([@B29]; [@B28]; [@B37]). Centriole duplication induced by PLK4 overexpression was reduced in human U2OS cells after RNA interference (RNAi) depletion of Cep135 ([@B28]). We therefore tested whether the ability of Plk4 to induce centriole formation is affected in the absence of Cep135 in DT40 cells. We observed supernumerary centriole formation in *Cep135* KO cells upon overexpression of chicken Plk4 ([@B42]; [Figure 7, A and B](#F7){ref-type="fig"}), suggesting that in DT40 cells Cep135 is probably dispensable for Plk4-induced centriole overduplication. Immunofluorescence microscopy analysis of the localization of Sas-6 and CP110 in Cep135-deficient cells showed that Cep135 deficiency had no detectable effect on the expression and localization of these proteins ([Figure 5, A and B](#F5){ref-type="fig"}), further supporting the conclusion that Cep135 deficiency has no major effect on centriole assembly in DT40 cells.

![HU-induced centrosome amplification is increased in *Cep135^−/--^* cells. (A) Wild-type, wild-type\*, and *Cep135* KO A1, A2, and B1 cell lines were transiently transfected with GFP-Plk4 and fixed 24 and 48 h after treatment. Micrographs showing the expression and effect of GFP-Plk4 (green) transfection after 48 h. Cells were stained with an antibody against centrin2 (red) and counterstained with DAPI. Insets show supernumerary centrosomes. Wild-type\*, parental DT40s for the B1 and B2 clones, included as an additional control. Scale bar, 5 μm. (B) Levels of centrosome amplification were quantified by immunofluorescence microscopy using an anti-centrin2 antibody in cells positive for GFP-Plk4. In wild-type, A1, and A2 cells, \<9% of cells contained more than two centrosomes when not expressing GFP-Plk4. Data represent mean ± SD of three separate experiments where at least 200 cells were counted for each time point. (C) Micrograph showing HU-treated, wild-type and *Cep135* KO A1 with multiple centrosomes. Cells were stained with antibodies against centrin2 (red) and γ-tubulin (green) and counterstained with DAPI. Scale bar, 5 μm. (D) Quantitation of HU-induced centrosome amplification using γ-tubulin as a marker. Data show mean ± SD of three separate experiments in which at least 200 cells were scored. \**p* ≤ 0.05, \*\*\**p* ≤ 0.001 in comparison with wild type, as calculated by a two-tailed unpaired Student\'s *t* test. (E) Quantitative analysis of wild-type, *Cep135* KO A1 and A2 DT40, and rescued *Cep135* KO A1 and A2 cell lines (*Cep135^−/−^::3myc-Cep135*) 24 h after treatment with 4 mM HU. Cells with more than two γ-tubulin spots were counted. Data show mean ± SD of three separate experiments in which at least 200 cells were scored. \*\**p* ≤ 0.01 in comparison with wild type, as calculated by a two-tailed unpaired Student\'s *t* test.](2645fig7){#F7}

Like many other cell types, DT40 cells undergo centrosome overduplication during prolonged cell cycle arrests that occur in response to genotoxic stresses, such as DNA double-strand break induction or replication fork stalling ([@B2]; [@B17]; [@B7]). To test whether this response depends on Cep135, we examined the centrosome reduplication capability of Cep135-deficient cells after hydroxyurea (HU) treatment. As shown in [Figure 7, C and D](#F7){ref-type="fig"}, HU treatment induced significantly higher levels of centrosome amplification in *Cep135* KO cell lines than in wild-type populations. Of importance, transgenic expression of 3myc-Cep135 in the Cep135-deficient cells restored HU-induced centrosome amplification levels to wild-type levels, confirming that this overamplification effect was dependent on Cep135 ([Figure 7E](#F7){ref-type="fig"}). Searching for a mechanism for how HU affects *Cep135*- deficient cells differently from wild-type cells, we tested whether Cdk2 level or Cdk2 phosphorylation at Thr-160 was changed in the absence of Cep135, as these are required for centrosome overduplication after HU treatment ([@B22]; [@B31]) or ionizing radiation ([@B6]). Immunoblot analysis revealed, however, no effect of Cep135 deficiency on Cdk2 levels or Cdk2 phosphorylation at Thr-160 after HU treatment (data not shown). Taken together, these results suggest that Cep135 plays a role in limiting HU-induced centrosome reduplication but has no clear effect on Plk4-induced centrosome amplification in DT40 cells.

In summary, we generated multiple independently derived clones of DT40 cells in which the *Cep135* locus was disrupted by gene targeting. Cep135-deficient cells proliferate normally and possess functional centrosomes that contain centrioles with normal ninefold symmetry. Because knockdown experiments indicate that Cep135 is required for normal centriole structures and Plk4-induced centriole overduplication in human cells ([@B28]; [@B30]), we did not expect to find such apparently normal centrioles in Cep135-deficient cells. The Cep135 orthologue, Bld10, is needed for centriole formation in *Chlamydomonas* ([@B32]) and *Paramecium* ([@B25]), with the overexpression of mutant forms of the protein giving rise to centrioles that have lost their ninefold symmetry ([@B24]). Similarly, RNAi experiments in *Drosophila* described a moderate effect of Cep135 knockdown on centrosome duplication ([@B16]). Whereas *Drosophila bld10*-mutant spermatocytes displayed mild perturbations of centriole structure and aberrant central-pair microtubules in the axoneme, mutant somatic cells showed no impairment in centrosome duplication ([@B33]; [@B9]; [@B38]). It is therefore possible that, whereas the role of Cep135 in stabilizing centriole structures is universal, rapidly cycling, transformed cells such as DT40s can assemble centrioles of normal appearance in the absence of Cep135. The small reduction in overall centriole numbers in Cep135-deficient cells indicates that in these cells, centriole biogenesis is mildly impaired.

Current understanding of cartwheel formation involves the association of Sas-6 homodimers through their N-terminal domains into a circular hublike structure from which the coiled-coil Sas-6 C-termini extend to form the spokes ([@B27]; [@B49]). Localization of Cep135 to these spokes in a number of organisms suggests that it might play a role in the cartwheel, at least in *Paramecium, Tetrahymena*, and *Chlamydomonas* ([@B32]; [@B24]; [@B25]; [@B4]). In *Drosophila* somatic cells, Bld10 localizes as a punctate area on both old and nascent centrioles, whereas in human cells Cep135 appears as a tight ring around the wall of the proximal end of the mother centrioles, with a much weaker signal overlapping with the cartwheel of the procentriole ([@B20]; [@B41]). Similarly, in DT40 cells, we observed a strong CEP135 localization on the proximal ends of mother centrioles throughout the cell cycle, with a prominent signal on procentrioles by early mitosis ([Figure 2E](#F2){ref-type="fig"}).

Consistent with an evolutionarily conserved functional link between Sas-6 and Cep135, *Drosophila bld10* mutants display unstable cartwheels and impaired connection between the cartwheel and centriolar microtubules ([@B38]). Cep135 seems to be required for the stabilization of Sas-6 rather than for the actual assembly of the cartwheel ([@B34]; [@B25]), in keeping with the direct interaction between Cep135 and Sas-6 observed in experiments using immunoprecipitation and recombinant protein pull downs ([@B30]). In addition to cartwheel assembly, *Drosophila* Sas-6 also promotes centriole cohesion ([@B44]). A role for Bld10/CEP135 in stabilizing basal body organization has been hypothesized from the analysis of ciliary function in *Drosophila* and *Tetrahymena* mutants of *Bld10*/*CEP135* ([@B4]; [@B9]). Loss of appropriate cartwheel-centriole attachment is therefore a possible explanation for both the atypical centriolar lumen structure that we see and the hyperamplification of centrioles in cells treated with HU. Indeed, the electron-dense nature and uniform appearance of this luminal structure could be consistent with a misplaced cartwheel. It is also feasible that the structure represents an ectopic cartwheel, which forms during or after centriole elongation. In mammalian cells, cartwheels are detectable in procentrioles but not in mature centrioles ([@B1]; [@B46]; [@B21]). This is likely to hold true in chicken cells, since cartwheels are rarely seen in our electron micrographs. Intriguingly, we observed the lumen structure in 34 of 40 Cep135-deficient centrioles, implying that unlike a normal cartwheel, this structure remains visible in mature centrioles. Further experiments will be necessary to establish the identity and biological meaning of this structure.

We propose that Cep135 promotes the maintenance of the cartwheel and thus contributes to cohesion between parental and nascent centrioles. Progressive loss/displacement of cartwheel structures was observed in *Drosophila bld10* mutants ([@B38]). Because DT40 cells exhibit a rapid 8-h cell cycle, premature loss of the cartwheel and centriole cohesion may have little effect on centriole formation or amplification during normal cell cycles. An unstable cartwheel structure could nonetheless lead to abortive procentriole assembly, consistent with the small increase in monopolar spindles and observed reduction in centriole numbers in these cells.

MATERIALS AND METHODS
=====================

Cell culture
------------

Chicken DT40 cells were cultured in RPMI 1640 medium with 10% fetal calf serum (FCS; Lonza, Basel, Switzerland) and 1% chicken serum (Sigma-Aldrich, St. Louis, MO) as previously described ([@B47]). HCT116 cells were a gift from B. Vogelstein (Johns Hopkins University, Baltimore, MD) and were cultured in DMEM with 10% FCS. In centriole amplification experiments, 5 × 10^6^ cells were resuspended in 100 μl of Kit T solution (Lonza) and mixed with 5 μg of endotoxin-free pEGFP-C1-Plk4 in 100 μl of the same solution ([@B42]). After nucleofection with program B-23 (Lonza), cells were resuspended in 10 ml of warmed medium. A similar approach was used for other transient transfections. For stable transfections, 10 × 10^6^ cells were electroporated with 30 μg of linearized constructs in a Gene Pulser Apparatus (Bio-Rad, Hercules, CA) with a voltage of 550 V at capacitance of 25 μF and then selected using antibiotics as previously described ([@B47]). Irradiation of cells was performed using a ^137^Cs source (Mainance Engineering, Waterlooville, United Kingdom). HU was from Sigma-Aldrich, and a 1 M stock solution was made up in dimethyl sulfoxide (DMSO). Centrosome overduplication was induced by treating cells with 4 mM HU. Monastrol was provided by Tocris Bioscience (Ellisville, MO) and used in a final concentration of 125 μM for 16 h.

Cloning
-------

Gene targeting constructs were generated by PCR on DT40 genomic DNA using the primers detailed in [Table 1](#T1){ref-type="table"}. Resistance cassettes were inserted into *Bam*HI sites in the final construct. A TAP ([@B8]) for insertion in-frame with *Cep135* was a gift from K. J. Patel (Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom). For cloning of the 3myc-*Cep135* construct, total RNA from DT40 cells was reverse transcribed using the SuperScript First-Strand synthesis kit (Invitrogen, Carlsbad, CA), and *Cep135* was amplified using KOD Hot Start Polymerase (EMD, San Diego, CA). The *Cep135* cDNA was subcloned into pGEM T-Easy, verified by sequencing, and subsequently cloned into pCMV-3TAG-2C (Stratagene, Santa Clara, CA). Similarly, chicken *CP110* was cloned by RT-PCR from DT40 cells, sequenced, and then inserted into pCMV-3TAG (Agilent, Santa Clara, CA).

###### 

Primers used in constructing *Cep135* targeting and expression constructs.

  Purpose                  Primer sequence (5′--3′)
  ------------------------ -----------------------------------
  KO Cep135 construct A    
  5′ arm forward           GCGGCCGCTGTGGGTTGACCTGTCTCT
  5′ arm reverse           GGATCCTAAAATATCGTTTGTTACAGC
  3′ arm forward           GGATCCCTATACAGGATTTACTCTTG
  3′ arm reverse           GGTACCTTGTTTTGACTAATCAACAGC
  KO Cep135 construct B    
  5′ arm forward           GAATTCTGCTACTATGCAACCAAATAACC
  5′ arm reverse           GGATCCTTATGATATCTCTAGCTTTTCTTGTAA
  3′ arm forward           GGATCCTAACTGCTGAACCAGCTTGAACAAGAA
  3′ arm reverse           GCGGCCGCTGCCAGTGAAGCATCTCCATCTTC
  TAP Cep135 construct     
  5′ arm forward           aagcttGCTAACTGAAGTTGCTGTCT
  5′ arm reverse           gaattcCTCCTTGAAGCTCACGTTTC
  3′ arm forward           ggatccCCAGTACTTGAGCAATCAAA
  3′ arm reverse           actagtAGTTGATCGTATCCCTGACT
  3myc-Cep135 construct    
  Chicken Cep135 forward   CCGCGGATGACGACAACAGCGGAGC
  Chicken Cep135 reverse   GGATCCTTACTCCTTGAAGCTCACGTTT
  KO Tsga10 construct      
  5′ arm forward           ATCGATTTGCAAGAGTGTGTGGAAGAA
  5′ arm reverse           GGATCCTTAGTTTGAATCCTGGGCTTTC
  3′ arm forward           GGATCCTGAACATCATCCCCTGAACG
  3′ arm reverse           ACTAGTTTGGTTCATCCACACTTCCA

Diagnostic and quantitative PCR
-------------------------------

Genomic DNA of clones was extracted using the Puregene Kit (Qiagen, Valencia, CA) and screened via PCR using the primers in [Table 2](#T2){ref-type="table"}. Primer locations on the *Cep135* locus are diagrammed in [Figures 1A](#F1){ref-type="fig"} and [2A](#F2){ref-type="fig"} and those for the *TSGA10* locus in Supplemental Figure S1. For quantitative PCR (qPCR), total RNA from wild-type and *Cep135* KO DT40 cells was isolated and reverse transcribed using the Superscript III First Strand Synthesis kit (Invitrogen). qPCR was performed using the Fast Sybr Green reaction mix (Applied Biosystems, Foster City, CA). Amplification and readout were carried out using the 7900HT Fast Real Time PCR System (Applied Biosystems) with the primers presented in [Table 3](#T3){ref-type="table"}. Data were analyzed applying the comparative *C*~T~ method ([@B39]).

###### 

Primers used in diagnostic PCR for gene targeting of *Cep135*.

  Primer                        Primer sequence (5′--3′)
  ----------------------------- --------------------------------------------------
  A                             GACCCGTACATTGCAGACCT
  B                             ACAAGAAACTACCACCTAAAAAGCA
  C                             AGCCAAGCTGGGCGTAATCATTACGAGGAGCGCTTTTGTTTTGTATTG
  D                             GCATTCCAATGTTGCTGCTA
  E                             GAGGGGACAGCACTAGGACA
  F for puromycin               GTCACCGAGCTGCAAGAACT
  F for neomycin                CGTTGGCTACCCGTGATATT
  F for blasticidin             CCCCCTGAACCTGAAACATA
  G for puromycin cassettes     GTCACCGAGCTGCAAGAACT
  G for neomycin cassettes      GACTTTCCTTTTCTGCCATCA
  G for blasticidin cassettes   CCCCCTGAACCTGAAACATA
  H                             TTGTGATAATCGCCAAGGTG
  I                             CGGTGGTCTTCTCGTCCATA
  J                             TCTGAAAACACACTTGCTTCG
  K                             TCGAGATTTCACTCAGCTCAA
  L                             ACGATTCTGGCATCGAAGTT

Letters indicate primers shown in [Figures 1A](#F1){ref-type="fig"} and [2A](#F2){ref-type="fig"} and Supplemental Figure S1.

###### 

Primers for *Cep135* qPCR.

  Primer                     Primer sequence (5′--3′)
  -------------------------- ---------------------------
  *GAPDH* forward            GCTCATCTGAAGGGTGGT
  *GAPDH* reverse            CATAAGACCCTCCACAAT
  *Cep135* exon 4 forward    CCTCCATCAGCTGTTAGTGCT
  *Cep135* exon 4 reverse    GTCTGCAATGTACGGGTCCT
  *Cep135* exon 6 forward    AAGAAATAGAACGCCTCATGCT
  *Cep135* exon 6 reverse    CTCATTGCTTTTACTTCTTGATTCC
  *Cep135* exon 13 forward   CAGACTGAGAAGAGAAGCAAAACAT
  *Cep135* exon 13 reverse   CTGCCAGTGAAGCATCTCC

Microtubule regrowth assay
--------------------------

For microtubule depolymerization, DT40 cultures were treated with 1 μg/ml nocodazole for 3 h. Cells were washed three times in ice-cold 1× phosphate-buffered saline (PBS; supplemented with 0.1% volume of DMSO) and adhered to poly-[l]{.smallcaps}-lysine slides for 10 min at 4°C on ice. Slides were submerged in growth media at 40°C for 1 min before methanol fixation and immunostaining.

Immunofluorescence microscopy
-----------------------------

Cells were washed in PBS and adhered to poly-[l]{.smallcaps}-lysine cover slips. Fixation was performed in ice-cold methanol for 5 min at −20°C, followed by a brief permeabilization using 0.1% Tween 20 in PBS. Visualization of ninein, Sas-6, and Aurora A required an additional permeabilization step using 1% Triton X-100/0.5% NP-40 in PBS for 5 min. Cells were then blocked in 5% bovine serum albumin in PBS for 5 min and incubated with primary antibodies for 1h at 37°C. The primary antibodies used in this study and their dilutions were as follows: mouse polyclonal against Cep135 ([@B36]) at 1:2000; mouse monoclonals against Sas-6 (BO1P; Abnova) at 1:50, α-tubulin (B512; Sigma-Aldrich) at 1:2000, γ-tubulin (GTU88; Sigma-Aldrich) at 1:150, γ-tubulin (C-20; Santa Cruz Biotechnology, Santa Cruz, CA) at 1:250, Aurora A (35C1; Abcam, Cambridge, MA) at 1:500, and glutamylated tubulin (GT335; a gift from C. Janke, Institut Curie, Paris, France; [@B51]) at 1:300; and rabbit polyclonals against centrin2 (poly6288; BioLegend, San Diego, CA) at 1:250, Cep76 (a gift from W. Tsang and B. Dynlacht, New York University School of Medicine, New York, NY; Tsang *et al.*, 2009) at 1:200, PCM1 (817; a gift from A. Merdes, University of Toulouse, Toulouse, France) at 1:5000, ninein (ab4447; Abcam) at 1:100, protein G (Abcam) at 1:1000, centrin3 (Abnova, San Jose, CA) at 1:1000, and TACC3 and CDK5RAP2 ([@B3]) at 1:1000.

For *Cep135^−/−^* cell lines A1 and A2, images were acquired using a BX51 microscope (Olympus, Tokyo, Japan) with 60× (numerical aperture \[NA\] 1.4) and 100× (NA 1.35) objectives and Openlab software (Improvision/PerkinElmer, Waltham, MA). Deconvolved (nearest-neighbor differential interference contrast) images were saved as Photoshop CS4 files (Adobe, San Jose, CA). For *Cep135^−/−^* cell lines B1 and B2, cells were analyzed with a confocal Nikon eclipse 90i microscope equipped with a 100× oil (NA 1.40) objective (Nikon, Melville, NY). We acquired 0.5-μm-step *Z*-stacks using an Eclipse C1Si camera driven by EZ-C1 software (Nikon). *Z*-stacks were projected in Volocity, version 5.0 (PerkinElmer), and exported as two-dimensional volume-rendered images into Photoshop CS4. Superresolution microscopy was performed using a three-dimensional structured illumination microscope by OMX DeltaVision (Applied Precision, Issaquah, WA). Cells were imaged with a 100× (NA 1.40) Olympus (Tokyo, Japan) objective. Data were reconstructed using SoftWorx software (Applied Precision).

Live cell imaging
-----------------

For live cell imaging, cells were allowed to attach to poly-[d]{.smallcaps}-lysine--coated dishes (MatTek, Ashland, MA) for 2--3 h in medium supplemented with 12.5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.5. Timing and light exposure were kept minimal by using reduced excitation light. Images were taken every 3 min for 3 h on an integrated microscope system (DeltaVision) using a PlanApo N 60× oil objective (NA 1.42) and a 39.5°C environmental chamber (WeatherStation; Precision Control, Sammamish, WA). Quick projections were made with SoftWorx software.

Transmission electron microscopy
--------------------------------

DT40 cells were prepared for TEM as previously described ([@B14]). Sections were cut on a microtome (Reichert-Jung Ultracut E; Leica, Wetzlar, Germany), stained with uranyl acetate and lead citrate, and then viewed on an electron microscope (H-7000; Hitachi, Tokyo, Japan). Images were taken with an ORCA-HRL camera (Hamamatsu Photonics, Hamamatsu, Japan) and processed using AMT, version 6 (Advanced Microscopy Techniques, Woburn, MA).

Flow cytometry
--------------

Cell cycle analysis by flow cytometry involved the treatment of cells with 5-bromo-2′-deoxyuridine (BrdU; Sigma-Aldrich) and visualization with antibodies to BrdU or phospho-histone H3 as previously described ([@B50]).

Western blot
------------

To obtain whole-cell extracts for Western blotting, cells were washed in PBS and lysed in 250 mM Tris, pH 7.6, 0.1% Triton X-100, 2.5 mM NaF, 1 mM Na~3~VO~4~, 2.5 mM ethylene glycol tetraacetic acid, 12.5 mM sodium pyrophosphate, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1 mM aprotinin, and 1 mM pepstatin. The primary antibodies used in this study were polyclonal rabbit anti-Cep135 ([@B36]), anti-Scc1 ([@B43]), anti--protein G (ab 7250; Abcam), Sas-6, anti--α-tubulin, and anti--β-actin (ab 8227; Abcam).
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:   5-bromo-2'-deoxyuridine
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:   dimethyl sulfoxide
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:   knockout
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:   microtubule

NA

:   numerical aperture

PCM
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:   red fluorescent protein

RNAi

:   RNA interference

TAP
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